What is the Loncar Cancer Immunotherapy ETF (CNCR) expense ratio?
The Loncar Cancer Immunotherapy ETF funds expense ratio is 0.79%.
What is Loncar Cancer Immunotherapy ETF (CNCR) current stock price?
As of the latest data, Loncar Cancer Immunotherapy ETF stock price is $9.02, with a previous close of $8.88. Loncar Cancer Immunotherapy ETF gained $0.14 in the last trading session, representing a 1.58% increase.
Does Loncar Cancer Immunotherapy ETF (CNCR) pay dividends?
No. Loncar Cancer Immunotherapy ETF does not pay a dividend.